Overview

Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity

Status:
Not yet recruiting

Trial end date:
2021-07-01

Target enrollment:

Participant gender:

Summary

The aim of the present study is to evaluate the potential adjuvant therapeutic effect of trimetazidine in treatment of acute AlP poisoning-induced cardiotoxicity.

Phase:

N/A

Details

Lead Sponsor:

Tanta University

Treatments:

Trimetazidine